BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15633942)

  • 1. Synaptophysin immunoreactivity in Pick's disease: comparison with Alzheimer's disease and dementia with Lewy bodies.
    Lippa CF
    Am J Alzheimers Dis Other Demen; 2004; 19(6):341-4. PubMed ID: 15633942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuritic pathology as a correlate of synaptic loss in dementia with lewy bodies.
    Revuelta GJ; Rosso A; Lippa CF
    Am J Alzheimers Dis Other Demen; 2008; 23(1):97-102. PubMed ID: 18276962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies.
    Elder GJ; Mactier K; Colloby SJ; Watson R; Blamire AM; O'Brien JT; Taylor JP
    Int J Geriatr Psychiatry; 2017 Nov; 32(11):1182-1189. PubMed ID: 28425185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch-1 immunoexpression is increased in Alzheimer's and Pick's disease.
    Nagarsheth MH; Viehman A; Lippa SM; Lippa CF
    J Neurol Sci; 2006 May; 244(1-2):111-6. PubMed ID: 16473372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Calbindin immunoreactivity in the dentate gyrus distinguishes Alzheimer's disease from other neurodegenerative dementias.
    Stefanits H; Wesseling C; Kovacs GG
    Neurosci Lett; 2014 Apr; 566():137-41. PubMed ID: 24569123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe panencephalic Pick's disease with Alzheimer's disease-like neuropil threads and synaptophysin immunoreactivity.
    Cochran EJ; Fox JH; Mufson EJ
    Acta Neuropathol; 1994; 88(5):479-84. PubMed ID: 7847079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of muscarinic acetylcholine receptors in atypical Pick's disease without Pick bodies.
    Odawara T; Shiozaki K; Iseki E; Hino H; Kosaka K
    J Neurol Neurosurg Psychiatry; 2003 Jul; 74(7):965-7. PubMed ID: 12810794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Proteome of the Dentate Terminal Zone of the Perforant Path Indicates Presynaptic Impairment in Alzheimer Disease.
    Haytural H; Mermelekas G; Emre C; Nigam SM; Carroll SL; Winblad B; Bogdanovic N; Barthet G; Granholm AC; Orre LM; Tjernberg LO; Frykman S
    Mol Cell Proteomics; 2020 Jan; 19(1):128-141. PubMed ID: 31699905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson's disease and dementia with Lewy bodies.
    Frigerio I; Bouwman MMA; Noordermeer RTGMM; Podobnik E; Popovic M; Timmermans E; Rozemuller AJM; van de Berg WDJ; Jonkman LE
    Acta Neuropathol Commun; 2024 Jan; 12(1):4. PubMed ID: 38173031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrophy of hippocampal subfields and adjacent extrahippocampal structures in dementia with Lewy bodies and Alzheimer's disease.
    Delli Pizzi S; Franciotti R; Bubbico G; Thomas A; Onofrj M; Bonanni L
    Neurobiol Aging; 2016 Apr; 40():103-109. PubMed ID: 26973109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old.
    Robinson JL; Molina-Porcel L; Corrada MM; Raible K; Lee EB; Lee VM; Kawas CH; Trojanowski JQ
    Brain; 2014 Sep; 137(Pt 9):2578-87. PubMed ID: 25012223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BetaII-tubulin and phospho-tau aggregates in Alzheimer's disease and Pick's disease.
    Puig B; Ferrer I; LudueƱa RF; Avila J
    J Alzheimers Dis; 2005 Jun; 7(3):213-20; discussion 255-62. PubMed ID: 16006664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing hippocampal atrophy in Alzheimer's dementia and dementia with lewy bodies.
    Chow N; Aarsland D; Honarpisheh H; Beyer MK; Somme JH; Elashoff D; Rongve A; Tysnes OB; Thompson PM; Apostolova LG
    Dement Geriatr Cogn Disord; 2012; 34(1):44-50. PubMed ID: 22922563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptic loss in Alzheimer's disease and other dementias.
    Hamos JE; DeGennaro LJ; Drachman DA
    Neurology; 1989 Mar; 39(3):355-61. PubMed ID: 2927643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia.
    Hansen LA; Daniel SE; Wilcock GK; Love S
    J Neurol Neurosurg Psychiatry; 1998 May; 64(5):653-6. PubMed ID: 9598683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.
    Whitwell JL; Weigand SD; Shiung MM; Boeve BF; Ferman TJ; Smith GE; Knopman DS; Petersen RC; Benarroch EE; Josephs KA; Jack CR
    Brain; 2007 Mar; 130(Pt 3):708-19. PubMed ID: 17267521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease.
    Wakabayashi K; Honer WG; Masliah E
    Brain Res; 1994 Dec; 667(1):24-32. PubMed ID: 7895080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of m1 muscarinic acetylcholine receptors in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies-an immunohistochemical study.
    Shiozaki K; Iseki E; Hino H; Kosaka K
    J Neurol Sci; 2001 Dec; 193(1):23-8. PubMed ID: 11718746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal inputs to hippocampal formation in Alzheimer's disease and in parkinsonism-dementia complex on Guam.
    Goto S; Hirano A
    Acta Neuropathol; 1990; 79(5):545-50. PubMed ID: 2109482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.